Title | A Phase 3, Open-Label, Randomized Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Obinutuzumab in Patients With Previously Untreated Chronic Lymphocytic Leukemia |
Protocole ID | BGB-11417-301 |
ClinicalTrials.gov ID | NCT06073821 |
Cancer Type(s) | Chronic Lymphocytic Leukemia |
Phase | Phase III |
Stage | |
Study Type | Clinical |
Drug | Sonrotoclax + zanubrutinib comparé à vénétoclax + obinutuzumab |
Institution |
CIUSSS DE L'ESTRIE – CENTRE HOSP. UNIV. DE SHERBROOKE
HOPITAL FLEURIMONT 3001 12e Avenue Nord, Sherbrooke, QC, J1H 5N4 |
City | |
Principal Investigator |
Dr. Dominique Toupin |
Coordinator |
Anick Champoux 819-346-1110 poste 12811 |
Status | Recruiting |
Activation Date | |
Eligibility Criteria |
|
Exclusion Criteria |
|